Ravish Dhirendra Barahia

Ravish Dhirendra Barahia

Director DIN 02293787
DIN 02293787 First appointment Jul 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravish Dhirendra Barahia

Data last updated:

Ravish Dhirendra Barahia was a Director at Arcus Trusteeship Services Private Limited (from 2012) and Director at Akela Clinical Research Private Limited (from 2008).

DIN 02293787
First Appointment 31 Jul 2008
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Mar 20122012Strike Off
Director31 Jul 20082007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arcus Trusteeship Services Private Limited
Akela Clinical Research Private Limited
Premium access

Shareholding and investment profile for Ravish Dhirendra Barahia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravish Dhirendra Barahia

Ravish Dhirendra Barahia was first appointed on 31 Jul 2008 as Director at Akela Clinical Research Private Limited. The most recent appointment on record is 14 Mar 2012 at Arcus Trusteeship Services Private Limited.

Ravish Dhirendra Barahia held 2 earlier board appointments: Arcus Trusteeship Services Private Limited (Director, from 14 Mar 2012); Akela Clinical Research Private Limited (Director, from 31 Jul 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available